Toxicity, biodegradation and elimination of polyanhydrides

被引:187
作者
Katti, DS
Lakshmi, S
Langer, R
Laurencin, CT
机构
[1] Univ Penn, Dept Chem Engn, Philadelphia, PA 19104 USA
[2] Med Coll Penn & Hahnemann Univ, Dept Orthoped Surg, Philadelphia, PA 19102 USA
[3] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
关键词
polyanhydrides; poly(anhydride-co-imides); biodegradation; biocompatibility; toxicity;
D O I
10.1016/S0169-409X(02)00052-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although originally developed for the textile industry, polyanhydrides have found extensive use in biomedical applications due to their biodegradability and excellent biocompatibility. Polyanhydrides are most commonly synthesized from diacid monomers by polycondensation. Efficient control over various physicochemical properties, such as biodegradability and biocompatibility, can be achieved for this class of polymers, due to the availability of a wide variety of diacid monomers as well as by copolymerization of these monomers. Biodegradation of these polymers takes place by the hydrolysis of the anhydride bonds and the polymer undergoes predominantly surface erosion, a desired property to attain near zero-order drug release profile. This review examines the mode of degradation and elimination of these polyanhydrides in vivo as well as the biocompatibility and toxicological aspects of various polyanhydrides. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:933 / 961
页数:29
相关论文
共 60 条
[1]   Effect of geometry on the erosion characteristics of polyanhydride matrices [J].
Akbari, H ;
D'Emanuele, A ;
Attwood, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 160 (01) :83-89
[2]   INTRAOPERATIVE CHEMICAL HEMOSTASIS IN NEUROSURGERY [J].
ARNAD, AG ;
SAWAYA, R .
NEUROSURGERY, 1986, 18 (02) :223-233
[3]   In vitro bone biocompatibility of poly(anhydride-co-imides) containing pyromellitylimidoalanine [J].
Attawia, MA ;
Uhrich, KE ;
Botchwey, E ;
Langer, R ;
Laurencin, CT .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1996, 14 (03) :445-454
[4]   CYTOTOXICITY TESTING OF POLY(ANHYDRIDE-CO-IMIDES) FOR ORTHOPEDIC APPLICATIONS [J].
ATTAWIA, MA ;
UHRICH, KE ;
BOTCHWEY, E ;
FAN, M ;
LANGER, R ;
LAURENCIN, CT .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (10) :1233-1240
[5]  
Attawia MA, 1999, J BIOMED MATER RES, V48, P322, DOI 10.1002/(SICI)1097-4636(1999)48:3<322::AID-JBM17>3.0.CO
[6]  
2-U
[7]  
Black J, 1999, BIOL PERFORMANCE MAT
[8]   QUANTITATIVE CORRESPONDENCE BETWEEN THE INVIVO AND INVITRO ACTIVITY OF TERATOGENIC AGENTS [J].
BRAUN, AG ;
BUCKNER, CA ;
EMERSON, DJ ;
NICHINSON, BB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06) :2056-2060
[9]   INTERSTITIAL CHEMOTHERAPY WITH DRUG POLYMER IMPLANTS FOR THE TREATMENT OF RECURRENT GLIOMAS [J].
BREM, H ;
MAHALEY, S ;
VICK, NA ;
BLACK, KL ;
SCHOLD, SC ;
BURGER, PC ;
FRIEDMAN, AH ;
CIRIC, IS ;
ELLER, TW ;
COZZENS, JW ;
KENEALY, JN .
JOURNAL OF NEUROSURGERY, 1991, 74 (03) :441-446
[10]   BIOCOMPATIBILITY OF A BIODEGRADABLE, CONTROLLED-RELEASE POLYMER IN THE RABBIT BRAIN [J].
BREM, H ;
KADER, A ;
EPSTEIN, JI ;
TAMARGO, RJ ;
DOMB, A ;
LANGER, R ;
LEONG, KW .
SELECTIVE CANCER THERAPEUTICS, 1989, 5 (02) :55-65